5 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18564796 | USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME IN PREPARATION OF DRUGS FOR TREATING ADVANCED SOLID TUMORS | PURDY, KYLE A | 1611 | Final Rejection | Nov 28, 2023 |
| 18286592 | USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME | RZECZYCKI, PHILLIP MATTHEW | 1625 | Non-Final OA | Oct 12, 2023 |
| 18269123 | PHARMACEUTICAL COMPOSITION OF MULTI-TARGET PROTEIN KINASE INHIBITORS, AND USE THEREOF | SHOWALTER, ALEXANDER KEITH | 1629 | Non-Final OA | Jun 22, 2023 |
| 18266870 | USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME | PALLAY, MICHAEL B | 1617 | Non-Final OA | Jun 13, 2023 |
| 18028960 | A CLASS OF FUSED RING COMPOUNDS, AND PREPARATION AND USE THEREOF | ROMERO, KRISTEN WANG | 1624 | Non-Final OA | Mar 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial